Acessibilidade / Reportar erro

Prophylactic Left Internal Mammary Artery Graft In Mildly-Stenosed Coronary Lesions. Still an Open Discussion

Keywords:
Coronary Artery Disease/surgery; Mocardial Revascularization; Mammary Arteries; Coronary Stenosis

I have read the article entitled "Prophylactic Left Internal Mammary Artery Graft in Mildly-Stenosed Coronary Lesions. Still An Open Discussion" by Evora et al.1 with great interest, recently published in Arquivos Brasileiros de Cardiologia. The investigators reported that the idea of a prophylactic left internal mammary artery (LIMA) on left anterior descending in mild-stenosed vessels is not confirmed yet by clinical evidence.11 Evora PRB, Arcêncio L, Schmidit A, Rodrigues AJ. Prophylactic left internal mammary artery graft In mildly-stenosed coronary lesions. Still an open discussion. Arq Bras Cardiol. 2016;106(3):168-70.

Berger at al.22 Berger A, MacCarthy PA, Siebert U, Carlier S, Wijns W, Heyndrickx G, et al. Long-term patency of internal mammary artery bypass grafts: relationship with preoperative severity of the native coronary artery stenosis. Circulation. 2004; 110(11 Suppl 1):36-40. reported that all moderate coronary lesions should be LIMA grafted during primary coronary bypass surgery.

Coronary angiography, anyhow quantitative, remains a relatively weak tool to determine the functional repercussion of a stenosis. Thus, it is likely that some lesions with a diameter stenosis < 50% were actually hemodynamically significant and, on the contrary, that stenoses with a diameter stenosis > 50% were not. Fractional flow reserve (FFR) is a guide wire-based index derived from intracoronary pressure measurements that has been shown to evaluate the functional significance of a coronary stenosis much more accurately than angiography.33 Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation. 1993;87(4):1354-67. 87(4):1354-67. FFR has been shown to be a predictable surrogate for noninvasive stress testing and is thus a useful tool in determining the suitability of revascularization.44 Bech GJ, De Bruyne B, Pijls NH, de Muinck ED, Hoorntje JC, Escaned J, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation. 2001;103(24):2928-34.

In the light of these knowledges, FFR might be a useful tool to evaluate moderate coronary lesions with regard to revascularization appropriateness.

References

  • 1
    Evora PRB, Arcêncio L, Schmidit A, Rodrigues AJ. Prophylactic left internal mammary artery graft In mildly-stenosed coronary lesions. Still an open discussion. Arq Bras Cardiol. 2016;106(3):168-70.
  • 2
    Berger A, MacCarthy PA, Siebert U, Carlier S, Wijns W, Heyndrickx G, et al. Long-term patency of internal mammary artery bypass grafts: relationship with preoperative severity of the native coronary artery stenosis. Circulation. 2004; 110(11 Suppl 1):36-40.
  • 3
    Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993;87(4):1354-67. 87(4):1354-67.
  • 4
    Bech GJ, De Bruyne B, Pijls NH, de Muinck ED, Hoorntje JC, Escaned J, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation 2001;103(24):2928-34.

Reply

The author(s) letter is based mainly on the excellent study carried out by Berger et al.11 Berger A, MacCarthy PA, Siebert U, Carlier S, Wijns W, Heyndrickx G, et al. Long-term patency of internal mammary artery bypass grafts: relationship with preoperative severity of the native coronary artery stenosis. Circulation. 2004;110(11Suppl 1):36-40. who reported that all moderate coronary lesions should be left internal mammary artery (LIMA) grafted during primary coronary bypass surgery.

Coronary angiography, anyhow quantitative, remains a relatively weak tool to determine the functional repercussion of a stenosis. In other words, the coronary angiography can underestimate the real degree of the artery obstruction. Fractional flow reserve might be a useful tool to evaluate moderate coronary lesions with regard to revascularization appropriateness.

Thank you very much for adding the important lesson that the “prophylactic left internal mammary artery graft in mildly-stenosed coronary lesions”, implies in the development of better tools. The coronary flow quantification improvement would be associated with a more comfortable adoption of the Berger opinion that “all moderate coronary lesions should be LIMA grafted during primary coronary bypass surgery”. However, the discussion remains open.22 Evora PRB, Arcêncio L, Schmidt A, Rodrigues AJ. Prophylactic left internal mammary artery graft In mildly-stenosed coronary lesions. Still an open discussion. Arq Bras Cardiol. 2016;106(3):168-70.

References

  • 1
    Berger A, MacCarthy PA, Siebert U, Carlier S, Wijns W, Heyndrickx G, et al. Long-term patency of internal mammary artery bypass grafts: relationship with preoperative severity of the native coronary artery stenosis. Circulation. 2004;110(11Suppl 1):36-40.
  • 2
    Evora PRB, Arcêncio L, Schmidt A, Rodrigues AJ. Prophylactic left internal mammary artery graft In mildly-stenosed coronary lesions. Still an open discussion. Arq Bras Cardiol. 2016;106(3):168-70.

Publication Dates

  • Publication in this collection
    July 2016

History

  • Received
    14 Mar 2016
  • Reviewed
    18 Mar 2016
  • Accepted
    18 Mar 2016
Sociedade Brasileira de Cardiologia - SBC Avenida Marechal Câmara, 160, sala: 330, Centro, CEP: 20020-907, (21) 3478-2700 - Rio de Janeiro - RJ - Brazil, Fax: +55 21 3478-2770 - São Paulo - SP - Brazil
E-mail: revista@cardiol.br